phrykt

Milestone Scientific Inc. (MLSS): who owns it and who trades it

As of Nov 16, 2026, no open-market insider purchases or sales of MLSS were reported in the last 12 months. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

No MLSS insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

MLSS short interest

Low short interest. 0.1% of MLSS shares are sold short: about 1 share in 1,127. Over the last 12 reports the number of shares short went down 93%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 78,756 MLSS shares were sold short, 0.1% of the shares outstanding, down 3.0% from the report before. At the average daily volume of 102,865 shares, buying them all back would take about 1.0 trading days (days to cover).

Shares short, % of all shares

0.09%May 15Oct 301.51%

Days to cover

1.0May 15Oct 302.4

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202678,7560.09%-3%102,8651.0
Oct 15, 202681,2170.09%-6%111,2961.0
Sep 30, 202686,3350.10%-5%78,3481.1
Sep 15, 202691,2880.10%+16%72,9741.2
Aug 31, 202678,5590.09%-62%124,9821.0
Aug 14, 2026209,3610.24%+85%258,8441.0
Jul 31, 2026113,4560.14%-32%112,7691.0
Jul 15, 2026166,2490.21%-37%126,8221.3
Jun 30, 2026262,5940.33%+25%274,9951.0
Jun 15, 2026209,5990.26%-60%159,5031.3
May 29, 2026528,7550.66%-50%234,8522.2
May 15, 20261.07M1.32%-58%700,7451.5

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Milestone Scientific company events

Milestone Scientific filed 10 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership, auditor). The latest was on Jul 31, 2026.

  1. Jul 31, 2026LeadershipMs. Kelly Ulto and Mr. Greg Shilling were elected by the Board of Directors of Milestone Scientific Inc. as directors and to the committees and in the positions indicated below at the meeting of the Board held on June 20, 2026, for terms ending at the Company’s 2026 annual meeting of stockholders… Filing
  2. Jul 29, 2026AnnouncementMilestone Scientific Inc. received notices of conversion from Benedetta Casamento, Dr. Didier Demesmin and Neal Goldman, each of whom is a director of the Company, with respect to the Company’s amended and restated promissory notes held by the Holders. Filing
  3. Jun 25, 2026LeadershipResignation . Shanth Thiyagalingam, a member of the Board of Directors since 2025, was nominated to continue as a director but has advised the Company that he has decided to devote his full time as chief executive officer of PainTEQ and to his family, and not to run for re-election. Filing
  4. May 6, 2026AuditorThe Board of Directors of Milestone Scientific Inc. approved the dismissal of CBIZ CPAs P.C. as the independent registered public accounting firm to the Company effective as of May 15, 2026. Filing
  5. May 6, 2026LeadershipThe Compensation Committee of the Board of Directors of Milestone Scientific Inc. approved a one-time stock option exchange program for outstanding stock options granted under the Company’s Amended and Restated 2020 Equity Incentive Plan and the applicable award agreements thereunder, held by Eric… Filing
  6. Apr 21, 2026AgreementMilestone Scientific Inc. entered into a securities purchase agreement with the purchasers named therein, for the private placement of an aggregate of 7,962,963 units, with each Unit consisting of (i) one share of the Company’s common stock, par value $0.001 per share, and (ii) one warrant to… Filing
  7. Apr 2, 2026AgreementMilestone Scientific Inc. entered into an amendment to the Amended and Restated Memorandum of Understanding, dated January 13, 2026, with Innovest S.p.A., as the holder of certain consent/blockage rights with respect to BP4 S.r.l., a society’ a responsibility’ limitation in liquidation. Filing
  8. Mar 11, 2026RulesChanged its bylaws or articles. Filing
  9. Jan 20, 2026AgreementMilestone Scientific Inc. entered into an Amended and Restated Memorandum of Understanding with Innovest S.p.A., as the holder of certain consent/blockage rights with respect to BP4 S.r.l., a society’ a responsibility’ limitation in liquidation. Filing
  10. Dec 23, 2025VoteReported shareholder vote results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Milestone Scientific financials

Famous investors that hold MLSS

1 of the 50 well-known investors we track reported holding MLSS in their latest 13F filing. The largest position is Ken Griffin's, worth $54.2K.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 2026135,051$54.2K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Milestone Scientific Inc. (MLSS) stock

Are MLSS insiders buying or selling?

No MLSS insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in MLSS?

As of Oct 30, 2026, 78,756 MLSS shares were sold short, 0.1% of the shares outstanding, down 3.0% from the report before. At the average daily volume of 102,865 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.

Which famous investors hold MLSS?

1 of the 50 well-known investors we track reported MLSS in their latest 13F filing, including Ken Griffin. The largest position is worth $54.2K. See all holders.

Executive pay

Milestone Scientific's chief executive was paid a total of $795K for the year ended Dec 31, 2025, down 10% from $881K the year before. In the last 12 months, Milestone Scientific's executives and directors bought no stock on the open market and sold none.

Chief executive, total pay$795KYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Other top executives, average$497KThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.